US · Healthcare

Moleculin Biotech Inc (MBRX)

Biotechnology

Moleculin Biotech Inc (MBRX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MBRX

P/E ratio

25.00

Moleculin Biotech Inc (MBRX) — FAQ

What is MBRX's P/E ratio?

The price-to-earnings (P/E) ratio for Moleculin Biotech Inc (MBRX) is 25.00 (data as of 2026-05-23).

Does Moleculin Biotech Inc pay a dividend?

Dividend yield is not available in the current snapshot for Moleculin Biotech Inc (MBRX). Check the MyAverix Finance app for the latest dividend data.

What sector is Moleculin Biotech Inc in?

Moleculin Biotech Inc (MBRX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MBRX listed on?

MBRX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)